A Refined LC-MS/MS Method Targeting Bile Acids from the Gut Microbiome

Posters | 2018 | Agilent Technologies | ASMSInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Clinical Research
Manufacturer
Agilent Technologies

Significance of the Topic


Secondary bile acids are abundant microbiota-derived metabolites that influence host physiology and serve as biomarkers for metabolic and gastrointestinal diseases.

Study Objectives and Overview


This work aimed to develop a targeted LC-MS/MS assay for 26 bile acids with enhanced selectivity, robustness, and minimal sample preparation, replacing traditional GC-MS approaches.

Instrumentation


  • UHPLC: Agilent 1290 Infinity II with Poroshell EC-C18 (2.1×150 mm, 2.7 μm) at 45 °C
  • Mass Spectrometer: Agilent 6470 Triple Quadrupole with Jet Stream ESI, positive/negative polarity switching, dynamic MRM

Methodology


  • Optimized 110 MRM transitions using MassHunter Optimizer
  • Mobile phases: A = 0.1% formic acid + 20 mM ammonium acetate in water; B = 0.1% formic acid in acetone
  • Gradient: 32% B for 6 min, ramp to 65% at 25 min, up to 98% at 25.1 min, total runtime 32.1 min
  • Sample preparation: methanol extraction and protein precipitation of plasma, methanol/water extraction of fecal samples

Key Results and Discussion


  • Baseline separation achieved for 24 of 26 bile acid isomers; improved lipid elution with acetone mobile phase
  • LLOQs ranged from 0.5 to 20 nM with calibration R² > 0.99 over 4.3 orders of magnitude
  • Robust performance over 200 injections with retention time CV < 0.15% and area CV ≈ 2.7%
  • Application to conventional and gnotobiotic mouse fecal extracts revealed drastically reduced secondary bile acid levels in germ-free animals

Benefits and Practical Applications


  • Enhanced selectivity and sensitivity in complex biological matrices
  • Minimal sample cleanup and reduced lipid carryover
  • High throughput profiling suitable for microbiome and clinical studies
  • Facilitates pathway mapping of bile acid metabolism using software tools

Future Trends and Applications


Integration with high-resolution metabolomics platforms, discovery of novel microbial metabolites, real-time clinical monitoring, and automation of sample preparation and data analysis.

Conclusion


The refined LC-MS/MS workflow provides a robust, sensitive, and high-throughput platform for comprehensive bile acid analysis, supporting advanced microbiome research and biomarker discovery.

References


1. Devlin AS, Fischbach MA. Nature Chem Biol. 2015;11(9):685-90
2. Wegner K et al. Anal Bioanal Chem. 2017;409(5):1231-45

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

A Refined LC/MS/MS Method Targeting Bile Acids from the Gut Microbiome
Tools to Understand the Gut Microbiome: A Refined LC-MS/MS Method to Profile Bacteria-derived Bile Acids
Deciphering the Microbiome: Targeted LC/MS/MS Analysis of Bile Acids in Biological Samples